PharmaVOICE Blog Post

How Innovative Trial Models Keep Your Active Trials on Track

Posted By: Dan Limbach
April 20, 2020

The ongoing COVID-19 pandemic continues to highlight the need for secure virtual capabilities and decentralized/hybrid approaches to clinical research models. Not only do these solutions maintain the momentum of current studies in times of disruption, but more importantly, they ensure that patients continue to receive access to life-saving treatments provided by clinical research.

As the ultimate healthcare-enabling research organization, Elligo has always worked toward solving the challenges that sponsors and physicians face, while facilitating clinical research as a healthcare option to patients at the right point of care. Our core model allows us to support trials anywhere in the United States and provide a full spectrum of solutions to help you support active studies, on-site and off-site.

Decentralized or Hybrid Model (SOARTM)

One of the many ways we ensure all patients have access to clinical research as a care option is our ability to run decentralized or hybrid trials efficiently and safely through our System of Accelerated Research (SOAR). This approach enables us to bring cutting-edge research to patients and their physicians, maintaining the trusted patient and physician relationship. Overall, this practice can lead to faster study startup times and higher retention as many patients wish to continue care with their own provider. We’re supported in our efforts through remote capabilities including virtual PSV/SIV, telemedicine, at-home visits for patients including in-home nurses and phlebotomists, and at-home screenings which ensure patients’ needs are met every step of the way.

 The Power of Data

Another way we support our active studies is through electronic health records (EHR) and state-of-the-art technology which utilizes the power of data for all aspects of your trial. Powered by IntElligo, our proprietary platform, we’re able to provide real-time data tracking for increased transparency into a clinical trial’s progress through this secure, remote monitoring technology. We also use EHR data through ResearchConnectTM to match practices to a trial using study criteria like therapeutic specialty, patient pool demographics, and office location to search EHRs and connect practices with upcoming clinical trial opportunities. Through this process, we have access to a diverse pool of over two million real-world patients that can be used in protocol review, development, and lab results to identify patients at the right point of care.

Direct Trial Oversight

Our project leadership team, made up of experienced project directors and project managers, help keep trials moving forward seamlessly by proactively identifying actionable trends and disseminating lessons learned across the network through their direct access to the trial, from startup to commercialization success. Not only do our experts serve as a main point of contact for trials, they regularly provide updates that help preclude any repeated mistakes across sites, which effectively increases efficiency in site management. By monitoring data and documentation, these skilled team members partner with physicians to train staff and provide the resources and tools needed to assimilate clinical research as a care option into a physician’s current workflows.

As clinical trial conduct continues to evolve, Elligo understands the need to work efficiently, safely, and inclusively to successfully provide continued access to research as a care option for patients.

Posted in: Clinical Trials, R&D

About the Blog Poster: Dan Limbach

Post a Comment

You must be logged in to post a Comment.

FEEDBACK